119 related articles for article (PubMed ID: 16178480)
1. Procalcitonin levels in peritoneal dialysis patients.
Opatrná S; Klaboch J; Opatrný K; Holubec L; Tomsů M; Sefrna F; Topolcan O
Perit Dial Int; 2005; 25(5):470-2. PubMed ID: 16178480
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
Lam MF; Leung JC; Lam CW; Tse KC; Lo WK; Lui SL; Chan TM; Tam S; Lai KN
Perit Dial Int; 2008; 28(4):377-84. PubMed ID: 18556380
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis.
Guz G; Colak B; Hizel K; Reis KA; Erten Y; Bali M; Sindel S
Perit Dial Int; 2006; 26(2):240-8. PubMed ID: 16623432
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin in patients with acute and chronic renal insufficiency.
Steinbach G; Bölke E; Grünert A; Störck M; Orth K
Wien Klin Wochenschr; 2004 Dec; 116(24):849-53. PubMed ID: 15690970
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
6. Pro-calcitonin and inflammation in chronic hemodialysis.
Trimarchi H; Dicugno M; Muryan A; Lombi F; Iturbe L; Raña MS; Young P; Nau K; Iriarte R; Pomeranz V; Forrester M; Karl A; Alonso M
Medicina (B Aires); 2013; 73(5):411-6. PubMed ID: 24152395
[TBL] [Abstract][Full Text] [Related]
7. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy.
Herget-Rosenthal S; Klein T; Marggraf G; Hirsch T; Jakob HG; Philipp T; Kribben A
Scand J Immunol; 2005 Feb; 61(2):180-6. PubMed ID: 15683455
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin: a new marker of inflammation in haemodialysis patients?
Level C; Chauveau P; Delmas Y; Lasseur C; Pellé G; Peuchant E; Montaudon D; Combe C
Nephrol Dial Transplant; 2001 May; 16(5):980-6. PubMed ID: 11328904
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis.
Dahaba AA; Rehak PH; List WF
Intensive Care Med; 2003 Apr; 29(4):579-83. PubMed ID: 12652350
[TBL] [Abstract][Full Text] [Related]
10. Markers of inflammation before and during peritoneal dialysis.
Palomar-Fontanet R; Lavin-Gómez BA; Quintanar-Lartundo JA; García-Unzueta MT; Gago-Fraile M; Torrealba-Rodríguez MI; Arias-Rodriguez MA; Gómez-Gerique JA
Adv Perit Dial; 2011; 27():28-32. PubMed ID: 22073824
[TBL] [Abstract][Full Text] [Related]
11. Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.
Lee WS; Kang DW; Back JH; Kim HL; Chung JH; Shin BC
Korean J Intern Med; 2015 Mar; 30(2):198-204. PubMed ID: 25750561
[TBL] [Abstract][Full Text] [Related]
12. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
13. Strong correlation of B2-microglobulin (B2-m) with procalcitonin (PCT) in the serum of chronic hemodialysis patients: a role for infections in the dialysis-related amyloidosis?
Kalocheretis P; Revela I; Spanou E; Drouzas A; Makriniotou I; Iatrou C
Ren Fail; 2008; 30(3):261-5. PubMed ID: 18350445
[TBL] [Abstract][Full Text] [Related]
14. Inflammation markers, chronic kidney disease, and renal replacement therapy.
Lavín-Gómez BA; Palomar-Fontanet R; Gago-Fraile M; Quintanar-Lartundo JA; Gómez-Palomo E; González-Lamuño D; García-Unzueta MT; Arias-Rodríguez MA; Gómez-Gerique JA
Adv Perit Dial; 2011; 27():33-7. PubMed ID: 22073825
[TBL] [Abstract][Full Text] [Related]
15. The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients.
Martino F; Scalzotto E; Giavarina D; Rodighiero MP; Crepaldi C; Day S; Ronco C
Perit Dial Int; 2015; 35(5):559-65. PubMed ID: 25395499
[TBL] [Abstract][Full Text] [Related]
16. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
17. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients.
Visvardis G; Griveas I; Fleva A; Giannakou A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou K; Sakellariou G
Ren Fail; 2005; 27(4):429-34. PubMed ID: 16060132
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin in peritoneal dialysis--a useful marker of inflammation?
Alscher DM; Mettang T
Perit Dial Int; 2005; 25(5):441-4. PubMed ID: 16178476
[No Abstract] [Full Text] [Related]
19. Procalcitonin serum levels in children undergoing chronic haemodialysis.
Lorton F; Veinberg F; Ielsch D; Deschênes G; Bensman A; Ulinski T
Pediatr Nephrol; 2007 Mar; 22(3):430-5. PubMed ID: 17043886
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis.
Kylänpää-Bäck ML; Takala A; Kemppainen EA; Puolakkainen PA; Leppäniemi AK; Karonen SL; Orpana A; Haapiainen RK; Repo H
Crit Care Med; 2001 Jan; 29(1):63-9. PubMed ID: 11176162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
